The spread of human leishmaniasis has prompted the scientific community to study dogs as reservoirs for Leishmania infantum. Canine leishmaniasis (CanL) is widespread in the Mediterranean area with a prevalence of up to 50%. The first step toward controlling the disease is to monitor its distribution, mainly in stray dogs. The validity of a recombinant K39 (rK39) dipstick test, a commercially available for the serodiagnosis of human leishmaniasis, was evaluated using sera from 165 dogs selected on the basis of positive or negative lymph node smears at parasitological examination. The results were compared with the indirect fluorescent antibody test (IFAT) (cutoff 1:80). Sera from a group of dogs with other diagnosed diseases but negative for leishmaniasis were also tested to evaluate any cross-reactivity. Various procedures were used for testing whole blood samples. The relative specificity of the rK39 dipstick and IFAT was 100% (97 of 97) and 98.97% (96 of 97), whereas the relative sensitivity was 97.06% (66 of 68) and 98.53% (67 of 68), respectively. The results of the dipstick and IFAT corresponded except for 2 sera (k ϭ 0.987). This data confirm the usefulness of rK39 antigen for diagnosing CanL both in symptomatic and asymptomatic dogs. The rK39 dipstick proved to be a rapid, sensitive, and specific test that may be very useful in the field for large-scale screening and also in veterinary practice, requiring minimal equipment and operator expertise.
Introduction
The importance of dog leishmaniasis due to Leishmania infantum has increased over the past decade not only in terms of its zoonotic potential, which is enhanced by emerging immune-suppressive diseases, 14, 27 but also because it is probably the most important canine protozoal disease in endemic areas. Canine leishmaniasis (CanL) is widespread in the Mediterranean area. In Italy, the prevalence of CanL ranges from 1.7% to 48.4% in the southern and central regions, 13 and recently, it has also spread to several northern regions. 4, 9 Canine leishmaniasis is characterized by a variety of clinical symptoms ranging from severe, and often fatal, to asymptomatic forms in more than 50% of dogs. 6, 22 The transmission of Leishmania spp. occurs when sand fly Phlebotominae vectors feed on both symptomatic and asymptomatic infected dogs 25 thus making both these groups of dogs significant for the transmission of human leishmaniasis and CanL. In this respect, the diagnosis of leishmaniasis is of paramount importance not only for human and animal health but also for monitoring disease epidemiology.
The definitive diagnosis of leishmaniasis requires the detection of parasites in tissues (e.g., spleen, bone marrow, or lymph nodes) by smears and culture. 17 Recently, a number of polymerase chain reaction (PCR) protocols have been used for the detection of Leishmania in humans 20 and dogs. 21 Serological diagnostic tools can easily identify asymptomatic carriers and are crucial for large-scale surveys. 3, 16 A number of serological tests for the detection of anti-Leishmania antibodies have been developed: the enzyme-linked immunosorbent assay (ELISA), 18 indirect fluorescent antibody test (IFAT), 12 immunoblotting assay, 32 direct agglutination test, and fast agglutination screening test 34 are the most commonly used. Among the serological tests, IFAT represents the gold standard for the diagnosis of CanL. 26 Over the past 10 years, serological diagnosis has involved the recombinant K39 (rK39) antigen, which is a repetitive immunodominant epitope of L. infantum, Leishmania chagasi, and Leishmania donovani tissue amastigotes. 8 The detection of circulating antibodies to rK39 antigen by ELISA seems to be indicative of active leishmaniasis in humans. 2, 8 Moreover, rK39 has been used to detect CanL by ELISA, 2, 31, 33 and it was found that anti-rK39 antibodies are more common in asymptomatic dogs than in hu-rK39 dipstick test for canine leishmaniasis serodiagnosis mans with subclinical visceral leishmaniasis. 33 An immunochromatographic dipstick test based on the rK39 antigen was used for the diagnosis of human visceral leishmaniasis induced by L. infantum, L. donovani, and L. chagasi and showed a sensitivity (Se) range of 67-100% and a high specificity (Sp) range of 97-100%. 5, 7, 19, 35, 36 Concerning the serodiagnosis of CanL, the immunochromatographic dipstick test has been compared with ELISA (using whole promastigotes) and PCR on buffy coat cells from peripheral blood, yielding an Se higher than that of PCR and comparable to that of ELISA but a lower Sp in comparison with the 2 above methods. 30 The aim of this study was to validate the rK39 dipstick test, available commercially for the serodiagnosis of human leishmaniasis, for the diagnosis of CanL using the parasitological microscopic examination as a gold standard. The performance characteristics of the rK39 dipstick test were then compared with those of the IFAT.
Materials and methods
Sample size. The minimum sample size (n ϭ 138) was calculated using the formula proposed by Greiner and Gardner 15 to estimate Se and Sp, with a 95% confidence interval, a 5% desired error margin, and 90% as an a priori estimate of Se. 11 Sampling procedures. A total of 165 dogs were bled with their owners' consent and divided into 3 groups as follows.
1) Group 1-Healthy dogs, negative control serum samples (n ϭ 55):
• Healthy dogs (n ϭ 33) with no history and no clinical signs of CanL, and negative lymph node smears, originating from an endemic area (Apulia region, southern Italy). • Healthy dogs (n ϭ 22) from a nonendemic area (Sweden) and that had never been abroad. 2) Group 2-Confirmed cases of CanL, positive control serum samples (n ϭ 68):
• Dogs with parasite-positive lymph node smears originating from an endemic area (Apulia region, southern Italy). The most frequently reported symptoms were: poor general condition, peripheral lymphadenopathy, exfoliative dermatitis, cutaneous ulcerations, conjunctivitis, onychogryphosis, and epistaxis. Symptoms featured different combinations and varying severity. 3) Group 3-Dogs with other documented diseases different from leishmaniasis (n ϭ 42):
• Dogs (n ϭ 24) with other diseases originating from an endemic area (Apulia region, southern Italy) with negative lymph nodes by microscopic examination. This group comprised dogs affected by neoplasms (n ϭ 5), endocrinopathy (n ϭ 4), pyodermitis (n ϭ 3), ehrlichiosis (n ϭ 3), sarcoptic or demodectic mange (n ϭ 3), canine distemper (n ϭ 1), lupus discoid (n ϭ 1), gastroenteritis (n ϭ 1), prostatitis (n ϭ 1), pul-monary foreign body (n ϭ 1), and cardiac tamponade (n ϭ 1). • Dogs (n ϭ 18) with other diseases originating from a nonendemic area (Sweden). This group included dogs with sarcoptic mange (n ϭ 9), ehrlichiosis (n ϭ 7), and borreliosis (n ϭ 2). For each dog, data were collected (i.e., sex, age, breed, environment) together with medical history, and a complete physical examination was performed. Brachial vein blood samples were taken, allowed to clot at room temperature, and centrifuged at 1,678 ϫ g for 10 min; sera were separated and stored at Ϫ20 C until testing. Serum protein electrophoresis was performed for each dog from the endemic area to detect the presence of hyperglobulinemia and/or an abnormal albumin-globulin ratio.
Direct parasitological observation of lymph node smears. The detection of parasites in lymph node smears was the criterion used to screen Leishmania-infected versus uninfected dogs in endemic areas because a definitive diagnosis of leishmaniasis requires evidence of the parasites. 10 Popliteal lymph nodes were sampled using a nonaspiration technique, 24 and the smears were prepared and stained with Giemsa. At cytology, the amastigotes (1.5-2.0 ϫ 2.5-5 m) contained a small, round nucleus and a short, rod-shaped kinetoplast.
Indirect fluorescent antibody test. Indirect fluorescent antibody test was performed by slightly modifying the procedures described by Mancianti and Meciani, 23 using promastigotes of L. infantum zymodeme MON1 as antigen. The parasitic cells were exposed to sera diluted (1:80) in phosphate-buffered saline (PBS), pH 7.2, in a moist chamber and after washing to fluoresceinated rabbit anti-dog IgG b diluted 1:40; both incubations were at 37 C for 30 min.
Samples were scored positive when they produced promastigote cytoplasmic or membrane fluorescence, using a cutoff dilution of 1:80. For each test, L. infantum-positive and L. infantum-negative canine sera were included as controls.
Immunochromatographic dipstick test. The dipstick test is a qualitative membrane-based immunoassay for the detection of anti-Leishmania antibodies in serum or plasma prepared for the diagnosis of human leishmaniasis. The membrane is precoated with rK39 antigen on the test line region and with anti-protein A antibodies (protein A colloidal gold conjugate) on the control line region. The test was performed according to the manufacturer's instructions (Product Code: 1603; Lot CF1079 and DF1060). a In brief, 20 l of serum was added into the sample well of the test device; then, 100 l of buffer, provided by the manufacturer with the kits, was added. The test was read 10 min after the addition of the serum. The results were positive if 2 distinct red or pink lines appeared (one in the test region and the other in the control region), negative when no red or pink lines appeared in the test region, and invalid if the control line failed to appear.
Evaluation of the dipstick test and IFAT. The test results were evaluated using the following indexes: Se (probability of a positive test when the infection is present), Sp (probability of a negative test when the infection is absent), likelihood ratio of a positive test result (LRϩ), and likelihood Sensitivity was assessed using sera from dogs with confirmed leishmaniasis (n ϭ 68). To determine the Sp of the tests, sera from parasitologically negative endemic (n ϭ 33) and nonendemic (n ϭ 22) healthy dogs or dogs with confirmed diseases other than leishmaniasis (n ϭ 42) were used.
The agreement between IFAT and dipstick was determined by kappa statistics with a 95% confidence interval, using Epiinfo software (http://www.cdc.gov/epiinfo/Epi6/ EI6dwni.htm).
Kappa values express agreement beyond chance, and a kappa value of 0.60-0.80 represents a substantial agreement beyond chance, whereas a kappa value of Ͼ0.80 represents almost perfect agreement beyond chance. 1 Samples that showed conflicting results were tested 3 times.
Dipstick test performed on whole blood. The usefulness of the dipstick in the detection of anti-Leishmania antibodies was tested using a drop of whole peripheral blood from a positive dog (IFAT titer 1:20,000) with 3 different procedures: 1) addition of 3 drops of the test buffer included in the kit to the air-dried blood in the well, 2) addition of 1 drop of fresh peripheral blood in the well immediately after 3 drops of test buffer, and 3) addition of 3 drops of test buffer in the well immediately after 1 drop of fresh peripheral blood. Dilution test. To evaluate the lowest level of anti-Leishmania antibodies detectable by the dipstick test, a serum sample positive at IFAT (1:10,000) was tested at different dilutions.
The positive serum sample was diluted in 1) a serum sample from a healthy dog from a nonendemic area, 2) distilled water, or 3) saline solution (NaCl 0.9%), up to the highest dilution giving positive results in the test. Furthermore, each diluent was also tested alone to detect false-positive reactions. Table 1 shows the results of the IFAT and rK39 dipstick tests for the detection of anti-Leishmania antibodies. No false-positive samples were detected in group 1 (healthy dogs), neither with IFAT nor with the dipstick test. Conversely, false-negative sera were detected among infected dogs (group 2) both at IFAT (n ϭ 1) and at the dipstick test (n ϭ 2). All the samples among the dogs with other diseases (group 3) from endemic and nonendemic areas were negative at the dipstick test. Only 1 sample specifically from an endemic area was positive at 1:80 at IFAT. Both the dipstick and IFAT tests showed very good performance characteristics: a very high Se and Sp, high LRϩ and low LRϪ, and a perfect agreement ( Table 2 ). In particular, the 2 tests matched in all but 2 samples, the first from a parasitologically positive dog, which was positive at IFAT (1:80 and 1:160) and negative at the dipstick test, and the second from a parasitologically negative dog (from an endemic area) with a documented diagnosis of canine monocytic ehrlichiosis (CME), which was positive at IFAT (1:80) and negative by the dipstick test. The serum protein electrophoresis showed hyperglobulinemia in all but one dog in group 2.
Results
Among the 3 procedures used to test the whole blood with the dipstick, the best results were obtained when 3 drops of test buffer were added to 1 drop of dried blood. Using the fresh peripheral blood, the re-rK39 dipstick test for canine leishmaniasis serodiagnosis sults were detectable only if the test buffer was dispensed into the well immediately before blood.
In the dilution trials, the highest dilutions of the serum (1:10,000 positive at IFAT), which produced positive results in the dipstick test, were 1:4,000, 1: 10,000, and 1:2,000,000 when the sample was diluted in serum from a healthy dog, distilled water, and saline solution, respectively.
The saline tested alone induced the appearance of a red-pink line in the test area (i.e., saline produces false positives), whereas the other 2 diluents tested alone did not produce any reaction in the test area.
Discussion
In this study, the results clearly show that the IFAT and rK39 dipstick tests are equally accurate for the detection of anti-Leishmania antibodies. The Se was 97.06% at the dipstick test and 98.53% at IFAT (at 1: 80, which is considered the cutoff in endemic areas). In 1 case only, a dog determined to be parasite positive on the basis of lymph node and cutaneous papules smears examination was negative with both IFAT and dipstick test. The same dog did not present evident symptoms of leishmaniasis and showed normal serum protein electrophoresis thus suggesting it was in a very early stage of the disease. It is difficult to explain the results of the tests on the serum of the other parasitepositive dog that was positive with IFAT and negative with the dipstick test.
The Sp of the IFAT was 98.97%, with 1 false positive in a dog from an endemic area, in which CME was diagnosed. In comparison, the dipstick showed an Sp of 100%, and no cross-reactions were detected in the course of either infectious (e.g., ehrlichiosis, borreliosis) or noninfectious diseases (e.g., neoplasms) in dogs from endemic and nonendemic areas. These findings confirm the high Sp already demonstrated by the rK39 dipstick test antigen for the differential diagnosis of human leishmaniasis from Chagas disease, malaria, schistosomiasis, and toxoplasmosis. 11 The results herein reported do not corroborate those reported by Reithinger et al., 30 who carried out a trial designed to validate the same test for the diagnosis of CanL and found that the dipstick test was associated with low Sp (i.e., 61% and 75% in comparison with PCR and ELISA, respectively), thus leaving a high proportion of dogs misdiagnosed as false positives. Also, the Se of the dipstick assay in this report (i.e., 97.06%) was higher than that reported by Reithinger et al., 30 i.e., 72% and 77% in comparison with PCR and ELISA, respectively.
The discrepancy between these findings and those of Reithinger et al. 30 may be attributed to the use of different approaches to estimate the true negative and positive population. In this study, the selection of pos-itive and negative dogs was made on the basis of positive or negative lymph node smears; in fact, direct parasitological detection is considered the best way to diagnose leishmaniasis in endemic areas. 17 Conversely, in Reithinger et al., 30 no microscopic detection of parasites was performed and the authors selected the positive and negative dogs on the basis of ELISA and PCR positivity or negativity. Indeed, although there are many advantages to using molecular tools for the diagnosis of CanL, PCR-based methodologies feature low Sp (i.e., yielding positive results even in the presence of inert genomic material) and lower Se in detecting asymptomatic dogs or dogs after treatment during follow-up. 28, 29 The results of this study corroborate those reported by Bern et al., 5 Brandonisio et al., 7 Jelinek et al., 19 Sundar et al., 35 and Zijlstra et al., 36 in which the rK39 dipstick test was used for the diagnosis of human visceral leishmaniasis, with an Sp of 97-100%.
On the whole, the Se and Sp values for the dipstick and IFAT tests are equally good, but the latter is both a qualitative method and a quantitative test that measures the titers of anti-Leishmania antibodies produced by dogs. On the other hand, the correct interpretation of IFAT results is subjective and depends on the operator's expertise, whereas the interpretation of the dipstick test is unequivocal.
Although the dipstick is not a quantitative test, the dilution trial showed that a serum sample positive at IFAT (1:10,000) was detectable at dilutions up to 1: 4,000 and 1:10,000 when diluted in a negative serum sample and in distilled water, respectively; this suggests that the test can detect even minute amounts of antibodies. Saline alone, even in the absence of serum samples, induced the appearance of a pink line in the test area thus producing false positives. This is a significant finding because under field conditions, e.g., in Sudan, with temperatures Ͼ40 C and low relative humidity, the serum had to be diluted in saline solution to perform the dipstick test. 36 The dilution of serum samples in saline solution caused false-positive results, 36 probably because of the addition of improper diluents.
Regarding the use of whole blood instead of serum for performing the dipstick test, the best results were obtained with dried blood; advantages include the possibility of collecting many samples in field conditions (with no need for laboratory equipment) thus facilitating large-scale surveys. This technique has already been tested successfully for diagnosing human visceral leishmaniasis under field conditions in India. 35 In conclusion, the dipstick could provide a very cost-effective alternative to currently available diagnostic tests, especially when used in large-scale surveys in which antibody titers are not required. The rK39 dipstick test is ideal for use under field conditions because it can be read visually and does not require laboratory equipment, electricity, or refrigeration. Moreover, whole blood can be collected, placed directly in the well, and tested at a later stage; furthermore, training required to perform the dipstick test is minimal compared with microscopic diagnosis, ELISA, IFAT, and PCR. Finally, the possibility of immediately observing the results and communicating them to dog owners also makes this test useful for the early diagnosis of CanL in normal veterinary practice and prevents delays in the treatment of affected dogs. However, it should be noted that in endemic areas a positive serological test may result from dogs that are recovering or harbor subclinical infection. Therefore, similar to all other serological tests, the rK39 dipstick test should be evaluated carefully according to the epidemiological context of the area and the aim of the investigation. In fact, the test may not perform as well as described in this study for detecting infection in the early stages. Rapid, sensitive, and specific diagnostic tests like the rK39 dipsticks in this study are particularly useful and extremely valuable in intervention campaigns for assessing the spread of CanL and consequently establishing prophylaxis against Phlebotominae vectors to prevent and reduce the incidence of canine and human leishmaniasis.
